BetaGlue Therapeutics’ Post

Our CEO Colin Story and CFO Salvatore Calabrese, will kick-off 2025 with the J.P. Morgan Healthcare Conference held from January 13-16, 2025. While in #SanFrancisco, they will be sharing their most recent pancreatic cancer data. Colin and Salvatore are looking forward to connecting with investors and potential partners to discuss BetaGlue's plans for the new year. If you would like to meet with us during the conference, please don’t hesitate to reach out – we would love to connect. See you in San Francisco! #HealthcareInnovation #JPM25 #betaglue #radiotherapy #innovation #oncology

  • graphical user interface, text, application
Like
Reply

To view or add a comment, sign in

Explore topics